Targeting Autophagy in Cardiovascular Disease

Autophagy is an important pathway for breaking down proteins and damaged organelles and may play an important role in reducing cardiovascular diseases. Discover the latest research on Targeting Autophagy in Cardiovascular Disease here.

June 20, 2020

Physiological and pathological regulation of autophagy in pregnancy

Archives of Gynecology and Obstetrics
Xiaoxuan ZhaoXiaoling Feng
July 1, 2020

Targeting the pathways of regulated necrosis: a potential strategy for alleviation of cardio-cerebrovascular injury

Cellular and Molecular Life Sciences : CMLS
Li-Qun LuJun Peng
June 21, 2020
Open Access

Bromide impairs the circadian clock and glycolytic homeostasis via disruption of autophagy in rat H9C2 cardiomyocytes

BMC Molecular and Cell Biology
Yicheng JiangXiwen Zhang
June 26, 2020

What We Learned about COVID-19 So Far? Notes from Underground

Turkish Thoracic Journal
Fatma Tokgöz AkyılMetin Akgün
July 6, 2020
Open Access

Long Noncoding RNAs: Important Participants and Potential Therapeutic Targets for Myocardial Ischaemia Reperfusion Injury

Clinical and Experimental Pharmacology & Physiology
Yu-Ming DingXiao-Sun Guo
June 17, 2020

Sophocarpine ameliorates cardiac hypertrophy through activation of autophagic responses

Bioscience, Biotechnology, and Biochemistry
Yue-Bao LinJiong-Hua Huang
July 6, 2020

Prophylactic (hydroxy)chloroquine in COVID-19: potential relevance for cardiac arrhythmia risk

Heart Rhythm : the Official Journal of the Heart Rhythm Society
Joost A OfferhausCarol Ann Remme
July 6, 2020

Autophagy in cardiovascular health and disease

Progress in Molecular Biology and Translational Science
Mahmoud AbdellatifSimon Sedej
June 25, 2020

COP9 Signalosome Suppresses RIPK1-RIPK3 mediated Cardiomyocyte Necroptosis in Mice

Circulation. Heart Failure
Peng XiaoXuejun Wang
July 3, 2020

Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: A State-of-the-Art Review

JACC. Basic to Translational Science
Gary D Lopaschuk, Subodh Verma
June 12, 2020

Outbreak of SARS-CoV2: Pathogenesis of infection and cardiovascular involvement

Hellenic Journal of Cardiology : HJC = Hellēnikē Kardiologikē Epitheōrēsē
Hamideh Amirfakhryan, Fatemeh Safari
June 23, 2020

Cardiac effects and toxicity of chloroquine: a short update

International Journal of Antimicrobial Agents
Kanigula Mubagwa
July 11, 2020
Open Access

Dysregulation of TCTP in Biological Processes and Diseases

Ulrich-Axel Bommer, Adam Telerman
June 20, 2020

CYLD exaggerates pressure overload-induced cardiomyopathy via suppressing autolysosome efflux in cardiomyocytes

Journal of Molecular and Cellular Cardiology
Lei QiTaixing Cui

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.


Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

© 2020 Meta ULC. All rights reserved